FDA Warning Letter — BOLIVE INC

Case 634004 — FEI 3013074455

The FDA took a Warning Letter action against BOLIVE INC on Jul 5, 2022 (Los Angeles, CA). The action was issued by CFSAN and concerns food/cosmetics products. This facility has 3 recent FDA inspections on record.

Action Details

Facility
BOLIVE INC
Date
Jul 5, 2022
Fiscal Year
2022
Product Type
Food/Cosmetics
Center
CFSAN
Location
Los Angeles, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.